Aims and objectives
To describe the experience in radiofrequency ablation (RFA) of hepatic focal lesions and the epidemiological profile of patients undergoing this procedure,
technique,
complications,
and results in a fourth level institution.
Methods and materials
Study design
A historical cohort study was carried out,
with a retrospective collection of information,
for patients treated by the radiology department at Fundación Cardioinfantil,
between January 2013 and April 2017,
with diagnosis of CHC,
either by imaging or histology,
who received management with ARF.
Data collection was done by reviewing the clinical history,
laboratory results and the local database of diagnostic images.
Population
Patients treated by the Radiology department at Fundación Cardioinfantil,
between January 2013 and April 2017,
with diagnostic imaging or histology of...
Results
Demographic characteristics
The majority of patients were male (57.6%),
with an average age of 65.1 years.
39.4% were taken to liver transplant in the course of their pathology (Table 1).
96 Normal 0 false false false ES-TRAD X-NONE X-NONE
Hepatocarcinoma was the most frequent cause of focal liver lesions,
of which 100% had underlying cirrhosis.
The most frequent etiology of cirrhosis was C hepatitis virus infection,
most of them CHILD A (Table 1).
Laboratories
96 Normal 0 false false false ES-TRAD X-NONE X-NONE
Although there...
Conclusion
RFA is a locoregional therapy for focal neoplastic liver lesions which use is increasing due to its high safety and efficacy.
In our population,
the majority of patients were men with a mean age of 65 years and liver cirrhosis as the most frequent underlying disease (96%),
similar to the demographic characteristics found in other studies [2,3].
The most frequent cause of cirrhosis in our patients was C hepatitis infection,
similar to that described by Zheng et al.
[4] and by [5] Kasuhiro et al.,...
References
Pugh RNH,
Murray Lyon IM,
Dawson JL,
Pietroni MC,
Williams R.
Transection of the oesophagus for bleeding oesophageal varices.
Br J Surg 1973;60:646–9.
Nieto IS de,
Santaolaya M.
Ablación por radiofrecuencia de los tumores hepáticos primarios y secundarios.
An Médicos 2013;58:163–8.
Ding J,
Jing X,
Wang Y,
Wang F,
Wang Y,
Du Z.
Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors.
Clin Radiol 2016;71:1270–6.
Zheng RN,
You ZJ,
Lin SH,
Jia J,
Cai YM,
Liu C,
et al.
Efficacy...